Literature DB >> 1974683

Inhalation delivery of asthma drugs.

H Matthys1.   

Abstract

In the immediate future, metered-dose inhalers (MDIs) with spacers remain the aerosol application of choice for topical steroids, mainly to reduce side effects. For beta 2-agonist, anticholinergics and prophylactic drugs, MDI (with or without demand valve), dry powder inhalers (multidose inhalers), ultrasonic or jet aerosol generators (with or without mechanical breathing assistance [IPPB]) are chosen according to the preference or the ability of the patients to perform the necessary breathing maneuvers as well as the availability of different products in different countries.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974683     DOI: 10.1007/bf02718189

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  7 in total

1.  [Aerosol therapy].

Authors:  H Matthys; D Köhler
Journal:  Prax Klin Pneumol       Date:  1988-06

2.  Efficiency of air compressor-driven nebulizers.

Authors:  W A Kradjan; S Lakshminarayan
Journal:  Chest       Date:  1985-04       Impact factor: 9.410

3.  Pulmonary deposition of aerosols by different mechanical devices.

Authors:  H Matthys; D Köhler
Journal:  Respiration       Date:  1985       Impact factor: 3.580

4.  The importance of particle size in response to inhaled bronchodilators.

Authors:  P J Rees; T J Clark; F Morén
Journal:  Eur J Respir Dis Suppl       Date:  1982

5.  The bronchodilator response from inhaled terbutaline is influenced by the mass of small particles: a study on a dry powder inhaler (Turbuhaler).

Authors:  G Persson; J E Wirén
Journal:  Eur Respir J       Date:  1989-03       Impact factor: 16.671

6.  New method for easy labeling of beta-2-agonists in the metered dose inhaler with technetium 99m.

Authors:  D Köhler; W Fleischer; H Matthys
Journal:  Respiration       Date:  1988       Impact factor: 3.580

7.  Intermittent positive pressure breathing therapy of chronic obstructive pulmonary disease. A clinical trial.

Authors: 
Journal:  Ann Intern Med       Date:  1983-11       Impact factor: 25.391

  7 in total
  3 in total

Review 1.  Spacer devices for metered dose inhalers.

Authors:  Stephen P Newman
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Novolizer: a multidose dry powder inhaler.

Authors:  Caroline Fenton; Gillian M Keating; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 3.  A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.

Authors:  Sanjeeva Dissanayake; Jason Suggett
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.